Maternal and foetal outcomes among 4118 women with HIV infection treated with lopinavir/ritonavir during pregnancy: analysis of population-based surveillance data from the national...

por Tookey, Pat A., Thorne, Claire, van Wyk, Jean, Norton, Michael
Publicado 2016

Outcomes related to 4864 pregnancies with exposure to lopinavir/ritonavir (LPV/r)

por Tookey, Pat, Thorne, Claire, Martinez-Tristani, Marisol, Norton, Michael, van Wyk, Jean
Publicado 2014

An indirect comparison of 144-week efficacy, safety, and tolerability of dolutegravir plus lamivudine and second-generation integrase inhibitor–based, 3-drug, single-tablet regimen...

por Evitt, Lee A., Nanji, Sakina, Grove, Richard A., Okoli, Chinyere, van Wyk, Jean, Snedecor, Sonya J.
Publicado 2023

Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppresse...

por Baril, Jean-Guy, Angel, Jonathan B., Gill, M. John, Gathe, Joseph, Cahn, Pedro, van Wyk, Jean, Walmsley, Sharon
Publicado 2016

898. Effectiveness and Tolerability of DTG + 3TC in Clinical Practice: Evidence in PLHIV from Real-world Data

por Evitt, Lee A, Kumar, Rahul, Kamath, Rahul, Jha, Diwakar, Parks, Daniel, van Wyk, Jean A, de Ruiter, Annemiek
Publicado 2021

The Association Between HIV Disclosure Status and Perceived Barriers to Care Faced by Women Living with HIV in Latin America, China, Central/Eastern Europe, and Western Europe/Cana...

por Loutfy, Mona, Johnson, Margaret, Walmsley, Sharon, Samarina, Anna, Vasquez, Patricia, Hao-Lan, He, Madihlaba, Tshepiso, Martinez-Tristani, Marisol, van Wyk, Jean
Publicado 2016

Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection

por Boffito, Marta, Waters, Laura, Cahn, Pedro, Paredes, Roger, Koteff, Justin, Van Wyk, Jean, Vincent, Tia, Demarest, James, Adkison, Kimberly, Quercia, Romina
Publicado 2020

1284. Suppressed Switch to DTG/3TC 2-Drug Regimen Vs. BIC- or DTG-Based 3-Drug Regimens

por Pierone, Gerald, Fusco, Jennifer S, Brunet, Laurence, Vannappagari, Vani, Sarkar, Supriya, Henegar, Cassidy, van Wyk, Jean A, Zolopa, Andrew, Fusco, Gregory P
Publicado 2022

1592. Real-World Utilization and Effectiveness of Long-Acting Cabotegravir + Rilpivirine Among People with HIV with Detectable Viral Loads at Initiation: Trio Cohort Study

por Elion, Rick A, Frick, Andrew, Radtchenko, Janna, Sridhar, Gayathri, Sarkar, Supriya, Eron, Joseph J, Mounzer, Karam, van Wyk, Jean A, Vannappagari, Vani
Publicado 2023

Postmarketing Surveillance of Pregnancy Outcomes With Dolutegravir Use

por Crawford, Melissa, van Wyk, Jean, Aboud, Michael, Vannappagari, Vani, Romach, Beth, Curtis, Lloyd, Wynne, Brian, de Ruiter, Annemiek, Smith, Kimberly, Payvandi, Nassrin
Publicado 2020

341. Risk of Type 2 Diabetes Mellitus after Antiretroviral Therapy Initiation in Individuals Living with HIV in the United States

por Hsu, Ricky, Brunet, Laurence, Fusco, Jennifer S, Mounzer, Karam, Vannappagari, Vani, Henegar, Cassidy, van Wyk, Jean A, Curtis, Lloyd D, Lo, Janet, Fusco, Gregory
Publicado 2019

886. The Impact of the COVID-19 Pandemic on Clinical Follow-Up, Monitoring and Regimen Discontinuation for People Living with HIV in the US

por Pierone, Gerald, Fusco, Jennifer S, Brunet, Laurence, Henegar, Cassidy, van Wyk, Jean A, Sarkar, Supriya, Vannappagari, Vani, Zolopa, Andrew, Wohlfeiler, Michael B, Fusco, Gregory
Publicado 2021

Evaluating Diversity in Randomized Clinical Trials of Dolutegravir-Based Antiretroviral Therapy Regimens: Pooled 48-Week Analyses by Race, Sex, and Regional Subgroups

por Rawlings, M Keith, Letang, Emilio, Quercia, Romina, Grove, Richard, DeMasi, Ralph, Min, Sherene, Vannappagari, Vani, Zolopa, Andrew, van Wyk, Jean, Smith, Kimberly
Publicado 2022

2842. Durable Efficacy of Two-Drug Regimen (2DR) of Dolutegravir (DTG) plus Lamivudine (3TC) in Antiretroviral Treatment-Naïve Adults with HIV-1 Infection at 96 Weeks: Subgroup Ana...

por van Wyk, Jean A, Man, Choy Y, Sievers, Jörg, Urbaityte, Rimgaile, Underwood, Mark, Tenorio, Allan R, Pappa, Keith, Wynne, Brian, Smith, Kimberly, Gartland, Martin
Publicado 2019

978. Changes in BMI Associated with Antiretroviral Regimens in Treatment-Experienced, Virologically Suppressed Individuals Living with HIV

por Mounzer, Karam, Brunet, Laurence, Hsu, Ricky, Fatukasi, Terra, Fusco, Jennifer S, Vannappagari, Vani, Henegar, Cassidy, van Wyk, Jean A, Crawford, Melissa, Lo, Janet, Fusco, Gregory
Publicado 2019

2484. Patient Reported Outcomes After Switching to a 2-Drug Regimen of Dolutegravir + Rilpivirine: Week 148 Results from the Sword-1 and Sword-2 Studies

por Oglesby, Alan, Angelis, Kostas, Punekar, Yogesh, Chounta, Vasiliki, Antela, Antonio, Matthews, Jessica, Kahl, Lesley, Gartland, Martin, Wynne, Brian, Murray, Miranda, Andre Van Wyk, Jean
Publicado 2019

1608. Real-World Effectiveness of Long-Acting Cabotegravir + Rilpivirine in Virologically Suppressed Treatment-Experienced Individuals: Two Years of Data from the OPERA(®) Cohort

por Sension, Michael, Hsu, Ricky K, Fusco, Jennifer S, Brunet, Laurence, Cochran, Quateka, Sridhar, Gayathri, Vannappagari, Vani, van Wyk, Jean A, Wohlfeiler, Michael B, Fusco, Gregory P
Publicado 2023

1028. Real-World Use of Long-Acting Cabotegravir + Rilpivirine in People with HIV with Detectable Viral Loads at Initiation: Findings from the OPERA(®) Cohort

por Hsu, Ricky K, Sension, Michael, Fusco, Jennifer S, Brunet, Laurence, Cochran, Quateka, Sridhar, Gayathri, Vannappagari, Vani, van Wyk, Jean A, Wohlfeiler, Michael B, Fusco, Gregory P
Publicado 2023

Brief Report: Evaluation of Inflammation and Atherogenesis Biomarkers Through 148 Weeks Postswitch to Dolutegravir and Rilpivirine in SWORD-1/SWORD-2

por Llibre, Josep M., López Cortés, Luis Fernando, Aylott, Alicia, Wynne, Brian, Matthews, Jessica, Van Solingen-Ristea, Rodica, Vandermeulen, Kati, van Wyk, Jean, Kahl, Lesley P.
Publicado 2022

1267. Efficacy and Safety of Switching to DTG/3TC in Virologically Suppressed PLWH by Age, Including Those Aged ≥65 Years: Pooled Results from the TANGO and SALSA Studies

por Prakash, Manyu, Grove, Richard, Wynne, Brian R, Man, Choy, van Wyk, Jean A, Jones, Clifford B, Okoli, Chinyere, Letang, Emilio, Ait-Khaled, Mounir, Clark, Andrew
Publicado 2022